Stress and 5-HT1B autoreceptors in models of anxiety

焦虑模型中的压力和 5-HT1B 自身受体

基本信息

  • 批准号:
    6761921
  • 负责人:
  • 金额:
    $ 5.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2005-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Serotonin (5-HT)1B autoreceptors are localized in the axon terminals of serotonergic neurons and provide feedback inhibition of serotonin synthesis and release. However, 5-HT1B receptors are expressed in many neuron types, making pharmacological analysis nearly unable to discern which populations produce a particular behavioral or physiological effect. This has led to confusion about their role in depressive and anxiety symptoms associated with impaired serotonergic neurotransmission. Most 5-HT fibers projecting to regions involved in these functions arise from the dorsal (DRN) or median (MRN) raphe nuclei, but there is considerable uncertainty as to how 5-HT release from these nuclei is controlled in disease states. We have been using viral gene transfer to examine the effects of DRN 5-HT1B over-expression on stress-sensitivity in two anxiety-related behaviors - open field test (OFT) and elevated-plus maze (EPM). In agreement with previous results showing increased DRN 5-HT1B expression in learned helpless rats, we found 5-HT1B overexpression in DRM increases anxiety behaviors. I propose to extend these studies to examine effects of 5-HT1B overexpression in the MRN, where I anticipate increased magnitude of EPM effects due to the involvement of MRN in benzodiazepine actions in this assay. To further establish the role of increased 5-HT1B autoreceptor expression in these effects, I will determine if SB-224289, a 5-HT1B antagonist reverses them. Finally. I will examine the effects of a key modulator of stress, corticotropin releasing factor (CRF), on 5-HT1B expression in the DRN. Since DRN and amygdala are reciprocally connected via 5-HT and CRF, investigating the functional relationship between CRF and 5-HT1B autoreceptors may help explain the interactions that these brain regions have in fear and anxiety behaviors. CRF has complex effects on 5-HT release from DRN projections, perhaps because both CRF receptors (R1 and R2) are expressed in DRN. CRF-R1 appears to inhibit 5-HT release, while CRF-R2 is excitatory. We propose to investigate the effect of subchronic infusion of selective CRF agonists into DRN on 5-HT1B mRNA regulation and anxiety behaviors. Chronic R1 activation should accordingly decrease 5-HT1B expression in DRN while increasing anxiety related behavior, while chronic R2 activation should produce the opposite effects.
描述(申请人提供):5-羟色胺(5-羟色胺)1B自身受体定位于5-羟色胺能神经元的轴突终末,并对5-羟色胺的合成和释放提供反馈抑制。然而,5-HT1B受体在许多类型的神经元中都有表达,这使得药理学分析几乎无法区分哪些群体产生了特定的行为或生理效应。这导致了人们对它们在与5-羟色胺能神经传递受损相关的抑郁和焦虑症状中所扮演的角色的困惑。投射到参与这些功能的区域的大多数5-羟色胺纤维来自中缝背核(DRN)或中缝正中核(MRN),但在疾病状态下这些核团如何控制5-羟色胺的释放仍有相当大的不确定性。我们一直使用病毒基因转移来检测DRN 5-HT1B过表达对两种与焦虑相关的行为--开场测试(OFT)和高架迷宫(EPM)--应激敏感性的影响。与先前在习得性无助大鼠中DRN 5-HT1B表达增加的结果一致,我们发现DRM中5-HT1B的过度表达会增加焦虑行为。我建议扩展这些研究以检验5-HT1B在MRN中的过度表达的影响,我预计由于MRN参与苯二氮卓类药物的作用,EPM效应的幅度会增加。为了进一步确定5-HT1B自身受体表达增加在这些效应中的作用,我将确定5-HT1B拮抗剂SB-224289是否能逆转这些作用。终于来了。我将研究应激的关键调节剂促肾上腺皮质激素释放因子(CRF)对DRN中5-HT1B表达的影响。由于DRN和杏仁核通过5-羟色胺和CRF相互联系,研究CRF和5-HT1B自身受体之间的功能关系可能有助于解释这些脑区在恐惧和焦虑行为中的相互作用。CRF对DRN投射的5-羟色胺的释放有复杂的影响,可能是因为CRF受体(R1和R2)都在DRN中表达。CRF-R1似乎抑制5-羟色胺的释放,而CRF-R2是兴奋的。我们建议研究选择性CRF激动剂亚慢性注入DRN对5-HT1B基因调控和焦虑行为的影响。因此,慢性激活R1应减少DRN中5-HT1B的表达,同时增加与焦虑相关的行为,而慢性R2激活应产生相反的效果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL S CLARK其他文献

MICHAEL S CLARK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL S CLARK', 18)}}的其他基金

The dorsal raphe and CRF: making the connections
中缝背侧和 CRF:建立联系
  • 批准号:
    7487726
  • 财政年份:
    2006
  • 资助金额:
    $ 5.44万
  • 项目类别:
The dorsal raphe and CRF: making the connections
中缝背侧和 CRF:建立联系
  • 批准号:
    7912937
  • 财政年份:
    2006
  • 资助金额:
    $ 5.44万
  • 项目类别:
The dorsal raphe and CRF: making the connections
中缝背侧和 CRF:建立联系
  • 批准号:
    7143656
  • 财政年份:
    2006
  • 资助金额:
    $ 5.44万
  • 项目类别:
The dorsal raphe and CRF: making the connections
中缝背侧和 CRF:建立联系
  • 批准号:
    7676032
  • 财政年份:
    2006
  • 资助金额:
    $ 5.44万
  • 项目类别:
The dorsal raphe and CRF: making the connections
中缝背侧和 CRF:建立联系
  • 批准号:
    7285235
  • 财政年份:
    2006
  • 资助金额:
    $ 5.44万
  • 项目类别:
Stress and 5-HT1B autoreceptors in models of anxiety
焦虑模型中的压力和 5-HT1B 自身受体
  • 批准号:
    6640511
  • 财政年份:
    2002
  • 资助金额:
    $ 5.44万
  • 项目类别:
Stress and 5-HT1B autoreceptors in models of anxiety
焦虑模型中的压力和 5-HT1B 自身受体
  • 批准号:
    6551489
  • 财政年份:
    2002
  • 资助金额:
    $ 5.44万
  • 项目类别:
REGULATION OF SEROTONIN SYNTHESIS IN NEURAL-LIKE CELLS
神经样细胞中血清素合成的调节
  • 批准号:
    2379147
  • 财政年份:
    1997
  • 资助金额:
    $ 5.44万
  • 项目类别:
REGULATION OF SEROTONIN SYNTHESIS IN NEURAL-LIKE CELLS
神经样细胞中血清素合成的调节
  • 批准号:
    2242102
  • 财政年份:
    1996
  • 资助金额:
    $ 5.44万
  • 项目类别:
REGULATION OF SEROTONIN SYNTHESIS IN NEURAL-LIKE CELLS
神经样细胞中血清素合成的调节
  • 批准号:
    2242100
  • 财政年份:
    1995
  • 资助金额:
    $ 5.44万
  • 项目类别:

相似海外基金

Neural Basis of Stress-Derailed Motherhood
压力脱轨母性的神经基础
  • 批准号:
    10666891
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics
利用 PET 研究微塑料和纳米塑料的体内命运和健康影响
  • 批准号:
    10890903
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Altered microglia states and microglia-endothelial cell axis in relation to white matter disease progression in VCID
VCID 中小胶质细胞状态和小胶质细胞内皮细胞轴的改变与白质疾病进展相关
  • 批准号:
    10738860
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
亚型选择性代谢型谷氨酸受体 PET 配体
  • 批准号:
    10576674
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
  • 批准号:
    10663717
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
糖原合成酶激酶 3 配体发现治疗阿尔茨海默病
  • 批准号:
    10637434
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Assessing Diffusion MRI Metrics for Detecting Changes of Synaptic Density in Alzheimer's Disease
评估弥散 MRI 指标以检测阿尔茨海默病突触密度的变化
  • 批准号:
    10739911
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
支持在吸烟者 2 期临床研究中评估 mGlu2 PAM SBP-9330 的安全性/毒理学、ADME 和 CMC 活动
  • 批准号:
    10829189
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Probing D2 and 5HT-2A mechanisms in early visual processing in V1
探索 V1 早期视觉处理中的 D2 和 5HT-2A 机制
  • 批准号:
    10605769
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
Develop in vivo PET imaging probes for ROCK2 as a biomarker of early Alzheimer's disease.
开发 ROCK2 的体内 PET 成像探针作为早期阿尔茨海默病的生物标志物。
  • 批准号:
    489145
  • 财政年份:
    2023
  • 资助金额:
    $ 5.44万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了